Vanderbilt-Ingram Cancer Center Archive — Page 24 of 28
-
November 9, 2017
Mathis strives to make her cancer journey meaningful
Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast. -
October 25, 2017
Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy
Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy. -
August 3, 2017
Investigators match novel cancer mutations with potential therapies
Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. -
June 8, 2017
Project reveals importance of cancer gene mutation testing
An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies. -
February 2, 2017
National Cancer Institute’s Lowy details HPV virus research efforts
Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. -
January 17, 2017
Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. -
August 17, 2016
Chicken Salad Chick Foundation gift to support Vanderbilt-Ingram Cancer Center research
Chicken Salad Chick Foundation founding board members Stacy Brown and Betty and Earlon McWhorter presented a $200,000 check to Vanderbilt-Ingram Cancer Center (VICC) to support cancer research. Among other initiatives, the Chicken Salad Chick Foundation was proud to host Music and Miracles Superfest, the first major stadium concert in Jordan-Hare’s 75-year history, held on April 23 in Auburn, Alabama.